Dose conversion factor between cyclosporine and tacrolimus in pediatric heart transplant recipients

J Heart Lung Transplant. 2014 Jul;33(7):766-8. doi: 10.1016/j.healun.2014.04.004. Epub 2014 Apr 21.

Authors

Eliza Notaro¹, Lisa Brown², Erin Albers³, Sabrina Law³, Mariska Kemna³

Affiliations

¹ School of Medicine, Seattle Children's Hospital, University of Washington, Seattle, Washington.
² Department of Biostatistics, Seattle Children's Hospital, University of Washington, Seattle, Washington.
³ Division of Pediatric Cardiology, Seattle Children's Hospital, University of Washington, Seattle, Washington.

PMID: 24854566
DOI: 10.1016/j.healun.2014.04.004

No abstract available

Publication types

Letter
Research Support, Non-U.S. Gov't

MeSH terms

Adolescent
Age Factors
Body Weight
Child
Child, Preschool
Cyclosporine / administration & dosage*
Cyclosporine / therapeutic use
Dose-Response Relationship, Drug
Female
Graft Rejection / prevention & control
Heart Transplantation*
Humans
Immunosuppressive Agents / administration & dosage*
Immunosuppressive Agents / therapeutic use
Infant
Male
Mathematical Computing*
Retrospective Studies
Tacrolimus / administration & dosage*
Tacrolimus / therapeutic use
Time Factors

Substances

Immunosuppressive Agents
Cyclosporine
Tacrolimus